Caribou Biosciences, Inc. (CRBU)
NASDAQ: CRBU · Real-Time Price · USD
1.900
-0.040 (-2.06%)
At close: Dec 5, 2025, 4:00 PM EST
1.895
-0.005 (-0.29%)
After-hours: Dec 5, 2025, 7:36 PM EST
Caribou Biosciences Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Net Income | -157.13 | -149.11 | -102.07 | -99.42 | -66.92 | -34.31 | |
| Depreciation & Amortization | 4.15 | 3.93 | 3.53 | 1.62 | 0.98 | 0.9 | |
| Loss (Gain) From Sale of Assets | -0.04 | -0.01 | -0.03 | - | 0 | 0.07 | |
| Asset Writedown & Restructuring Costs | 12.15 | 1.63 | - | 0.6 | 1 | 3.13 | |
| Loss (Gain) From Sale of Investments | -2.02 | -4.62 | -4.42 | -0.66 | 0.05 | 0.73 | |
| Stock-Based Compensation | 13.85 | 16.71 | 13.75 | 11.72 | 3.45 | 1 | |
| Other Operating Activities | 0.89 | -1.62 | 3.28 | -0.62 | -0.15 | -4.92 | |
| Change in Accounts Receivable | -0.12 | 0.15 | 0.88 | 0.19 | -1.16 | -0.64 | |
| Change in Accounts Payable | 1.11 | -0.35 | 1.82 | -2.72 | 1.14 | 0.04 | |
| Change in Unearned Revenue | -2.8 | -2.5 | -16.94 | -4.84 | 29.64 | -0.61 | |
| Change in Other Net Operating Assets | -4.83 | -2.4 | 6.75 | 3.26 | -0.87 | 1.87 | |
| Operating Cash Flow | -125.64 | -138.2 | -93.29 | -90.97 | -32.52 | -33.22 | |
| Capital Expenditures | -2.09 | -4.88 | -11.61 | -6.45 | -2.12 | -0.32 | |
| Sale of Property, Plant & Equipment | 0.01 | 0.01 | - | - | - | 0.01 | |
| Sale (Purchase) of Intangibles | - | -1.63 | - | -0.6 | -1 | -1 | |
| Investment in Securities | 102.28 | 93.1 | -56.57 | -86.2 | -173.28 | 7.67 | |
| Investing Cash Flow | 100.2 | 86.61 | -68.18 | -93.25 | -176.4 | 6.36 | |
| Long-Term Debt Issued | - | - | - | - | 1.15 | 1.58 | |
| Long-Term Debt Repaid | - | - | - | - | -0.12 | -0.11 | |
| Net Debt Issued (Repaid) | - | - | - | - | 1.03 | 1.47 | |
| Issuance of Common Stock | 4.61 | 16.72 | 154.3 | 2.13 | 323.57 | 0.27 | |
| Financing Cash Flow | 4.61 | 16.72 | 154.3 | 2.13 | 433.43 | 1.74 | |
| Net Cash Flow | -20.83 | -34.87 | -7.18 | -182.08 | 224.51 | -25.12 | |
| Free Cash Flow | -127.73 | -143.08 | -104.9 | -97.42 | -34.64 | -33.53 | |
| Free Cash Flow Margin | -1374.19% | -1431.66% | -304.27% | -703.34% | -360.91% | -271.27% | |
| Free Cash Flow Per Share | -1.38 | -1.58 | -1.42 | -1.60 | -1.09 | -3.92 | |
| Cash Income Tax Paid | - | - | 0.17 | - | 0.01 | 0.02 | |
| Levered Free Cash Flow | -76.1 | -84.9 | -64.36 | -56.11 | -33.46 | -21.16 | |
| Unlevered Free Cash Flow | -76.1 | -84.9 | -64.36 | -56.11 | -33.46 | -21.15 | |
| Change in Working Capital | -6.65 | -5.11 | -7.32 | -4.2 | 29.07 | 0.18 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.